LGND EPS Estimates
Ligand Pharmaceuticals Incorporated
$294.99
-$8.54(-2.81%)
69
Overall
75
Value
63
Tech
71
Quality
Market Cap
$5.88B
Volume
245.28K
52W Range
$175.89 - $326.63
Target Price
$344.25
LGND EPS estimates: the consensus estimate for Ligand Pharmaceuticals Incorporated's current fiscal year is $5.25 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
LGND EPS Estimates
- EPS estimate, current quarter
- $1.42
- EPS estimate, next quarter
- $2.15
- EPS estimate, current year
- $5.25
- EPS estimate, next year
- $8.35
- EPS growth, 3-year
- +73.83%
| Fiscal year | EPS |
|---|---|
| 2025 | $6.44 |
| 2024 | $-1.64 |
| 2023 | $3.02 |
| 2022 | $-1.98 |
| 2021 | $2.15 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $294.99 | -2.8% | 245.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW